Acadia Healthcare Company, Inc. — The Khrom reporting group amended its Schedule 13D disclosing aggregate beneficial ownership of 7,457,311 Shares of Common Stock as of March 10, 2026, representing approximately 8.09% of outstanding shares.
The filing states Khrom Investments directly holds 7,450,383 Shares, Khrom Capital has shared voting and dispositive power over those same 7,450,383 Shares, and Eric Khrom directly holds 6,928 Shares, for an aggregate total of 7,457,311 Shares. The outstanding share base cited is 92,211,777 Shares as of February 25, 2026 per the Issuer's Annual Report on Form 10-K.
Positive
None.
Negative
None.
Insights
Khrom group discloses an >8% stake and shared control structure.
The filing records aggregate beneficial ownership of 7,457,311 Shares (about 8.09%) as of March 10, 2026. It explains the ownership chain: Khrom Investments is the direct holder and Khrom Capital and Eric Khrom hold voting/dispositive powers through affiliated entities.
Key dependencies include the Issuer's outstanding share count of 92,211,777 Shares as of February 25, 2026. Subsequent filings would be needed to show any change in holdings or intent.
Disclosure clarifies who controls the reported shares but does not state transaction intent.
The Schedule indicates who holds and who exercises voting or dispositive power: Khrom Investments holds the shares, Khrom Capital exercises shared power, and Eric Khrom may be deemed to share power by virtue of his roles.
Cash‑flow treatment and any plans (e.g., sales, proposals) are not stated in the excerpt; future regulatory filings would reflect changes in position or intent.
What stake does the Khrom group report in Acadia Healthcare (ACHC)?
They report beneficial ownership of 7,457,311 Shares, approximately 8.09% of the class. The filing cites 92,211,777 Shares outstanding as of February 25, 2026 from the company's Form 10-K.
How are the Khrom holdings allocated among filing entities?
Khrom Investments directly holds 7,450,383 Shares and Eric Khrom directly holds 6,928 Shares. Khrom Capital has shared voting and dispositive power over the 7,450,383 Shares held by Khrom Investments.
Does the filing state any intent to buy or sell ACHC shares?
No. The amendment describes current beneficial ownership and voting/dispositive arrangements but does not state any plans to buy, sell, or seek control in the provided excerpt.
What basis is used to calculate the 8.09% ownership percentage?
The percentage is calculated using an outstanding share count of 92,211,777 Shares as of February 25, 2026, cited from the Issuer's Annual Report on Form 10-K filed February 27, 2026.
Who signed the amendment disclosing these holdings?
The filing is signed by Eduard Skutelsky as Chief Operating Officer on behalf of the reporting entities and by Eric Khrom on 03/11/2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Acadia Healthcare Company, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
03/10/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Khrom Investments Fund, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
7,450,383.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
7,450,383.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,450,383.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.08 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Khrom Capital Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NEW YORK
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,450,383.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,450,383.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,450,383.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.08 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
1
Names of Reporting Persons
Eric Khrom
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FLORIDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
6,928.00
6
Shared Voting Power
7,450,383.00
7
Sole Dispositive Power
6,928.00
8
Shared Dispositive Power
7,450,383.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,457,311.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.09 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Acadia Healthcare Company, Inc.
(b)
Address of issuer's principal executive offices:
6100 TOWER CIRCLE, SUITE 1000, FRANKLIN, TN, US, 37067
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed on behalf of each of the following persons (collectively, the "Reporting Persons"): (i) Khrom Investments Fund, LP ("Khrom Investments"); (ii) Khrom Capital Management LLC ("Khrom Capital"); and (iii) Mr. Eric Khrom.
This Schedule 13G amends the Schedule 13D relating to the shares of common stock, par value $0.01 per share (the "Shares"), issued by Acadia Healthcare Company, Inc. (the "Issuer"), which was originally filed by the Reporting Persons on October 1, 2025 (the "Original 13D"), as amended by Amendment No. 1 to the Original Schedule 13D filed by the Reporting Persons on November 24, 2025, and as further amended by Amendment No. 2 to the Original Schedule 13D filed by the Reporting Persons on January 23, 2026 (as amended, this "Schedule 13D"). Capitalized terms used herein and not otherwise defined have the respective meanings ascribed thereto in the Original 13D.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is c/o Khrom Capital Management LLC, 1691 Michigan Ave, Suite 240, Miami, FL 33139.
(c)
Citizenship:
Khrom Investments is a Delaware limited partnership. Khrom Capital is a New York limited liability company. Mr. Khrom is a resident of Florida.
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP No.:
00404A109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of March 10, 2026, the Reporting Persons may be deemed to beneficially own in the aggregate 7,457,311 Shares.
(b)
Percent of class:
As of March 10, 2026, the Reporting Persons may be deemed to beneficially own in the aggregate 7,457,311 Shares, representing approximately 8.09% of the Issuer's outstanding Shares (based on 92,211,777 outstanding Shares as of February 25, 2026, as set forth in the Issuer's Annual Report on Form 10-K filed with the SEC on February 27, 2026).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information set forth on the cover pages hereto and Item 4(a) is hereby incorporated in its entirety herein. Khrom Investments is the direct beneficial owner of 7,450,383 Shares and Mr. Khrom is the direct beneficial owner of 6,928 Shares. The Shares reported as beneficially owned by Khrom Capital reflect the Shares that are directly beneficially owned by its affiliate, Khrom Investments, as Khrom Capital has the power to vote or direct the vote of (and the power to dispose or direct the disposition of) such Shares. Mr. Khrom is the sole member of Khrom Capital GP, LLC, which is the general partner of Khrom Investments. Mr. Khrom in his capacity as the managing member of Khrom Capital and as the sole member of Khrom Capital GP, LLC may be deemed to share the power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Shares directly beneficially owned by Khrom Investments and, accordingly, Mr. Khrom may be deemed to be the beneficial owner of such Shares. Mr. Khrom disclaims beneficial ownership of the Shares directly held by Khrom Investments except to the extent of any pecuniary interest therein.
(ii) Shared power to vote or to direct the vote:
The information set forth on the cover pages hereto and Item 4(a) is hereby incorporated in its entirety herein.
(iii) Sole power to dispose or to direct the disposition of:
The information set forth on the cover pages hereto and Item 4(a) is hereby incorporated in its entirety herein.
(iv) Shared power to dispose or to direct the disposition of:
The information set forth on the cover pages hereto and Item 4(a) is hereby incorporated in its entirety herein.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Schedule 13G, except that dividends from, and proceeds from the sale of, the Shares held by the accounts managed by Khrom Capital, including the Shares that are directly beneficially owned by Khrom Investments, may be delivered to such accounts.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
